Advertisement

Newton biotech firm AesRx LLC has boosted its latest financing round by about $125,000 to $1.5 million, according to a federal document.

AesRx filed in May with the U.S. Securities and Exchange Commission the first tranche of the debt and equities funding for a value of $1.375 million. The top end of the planned round hasn’t changed with the new funding, staying at $3.5 million.

SOURCE

Advertisement
Advertisement